Literature DB >> 15147269

The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase.

Shingo Toji1, Norikazu Yabuta, Toshiya Hosomi, Souichi Nishihara, Toshiko Kobayashi, Susumu Suzuki, Katsuyuki Tamai, Hiroshi Nojima.   

Abstract

Human Lats2, a novel serine/threonine kinase, is a member of the Lats kinase family that includes the Drosophila tumour suppressor lats/warts. Lats1, a counterpart of Lats2, is phosphorylated in mitosis and localized to the mitotic apparatus. However, the regulation, function and intracellular distribution of Lats2 remain unclear. Here, we show that Lats2 is a novel phosphorylation target of Aurora-A kinase. We first showed that the phosphorylated residue of Lats2 is S83 in vitro. Antibody that recognizes this phosphorylated S83 indicated that the phosphorylation also occurs in vivo. We found that Lats2 transiently interacts with Aurora-A, and that Lats2 and Aurora-A co-localize at the centrosomes during the cell cycle. Furthermore, we showed that the inhibition of Aurora-A-induced phosphorylation of S83 on Lats2 partially perturbed its centrosomal localization. On the basis of these observations, we conclude that S83 of Lats2 is a phosphorylation target of Aurora-A and this phosphorylation plays a role of the centrosomal localization of Lats2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147269     DOI: 10.1111/j.1356-9597.2004.00732.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  53 in total

1.  The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.

Authors:  Yael Aylon; Yaara Ofir-Rosenfeld; Norikazu Yabuta; Eleonora Lapi; Hiroshi Nojima; Xin Lu; Moshe Oren
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

2.  Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.

Authors:  Chu Zhu; Xinyan Ji; Haitao Zhang; Qi Zhou; Xiaolei Cao; Mei Tang; Yuan Si; Huan Yan; Li Li; Tingbo Liang; Xin-Hua Feng; Bin Zhao
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

3.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Lu Zhou; Chenyi Yang; Hediye Erdjument-Bromage; David Zagzag; Matija Snuderl; Marc Ladanyi; C Oliver Hanemann; Pengbo Zhou; Matthias A Karajannis; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

4.  Tumor suppressor NF2/Merlin is a microtubule stabilizer.

Authors:  Zlatko Smole; Claudio R Thoma; Kathryn T Applegate; Maria Duda; Katrin L Gutbrodt; Gaudenz Danuser; Wilhelm Krek
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

Review 5.  The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

Authors:  Xiao-Lan Liu; Rui Zuo; Wen-Bin Ou
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

6.  The NDR kinase DBF-2 is involved in regulation of mitosis, conidial development, and glycogen metabolism in Neurospora crassa.

Authors:  Efrat Dvash; Galia Kra-Oz; Carmit Ziv; Shmuel Carmeli; Oded Yarden
Journal:  Eukaryot Cell       Date:  2009-12-04

Review 7.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

8.  KIBRA regulates aurora kinase activity and is required for precise chromosome alignment during mitosis.

Authors:  Lin Zhang; Jyoti Iyer; Aparajita Chowdhury; Ming Ji; Ling Xiao; Shuping Yang; Yuanhong Chen; Ming-Ying Tsai; Jixin Dong
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

9.  Aurora A kinase modulates actin cytoskeleton through phosphorylation of Cofilin: Implication in the mitotic process.

Authors:  Lisa Ritchey; Ratna Chakrabarti
Journal:  Biochim Biophys Acta       Date:  2014-08-01

10.  Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.

Authors:  Y Aylon; N Yabuta; H Besserglick; Y Buganim; V Rotter; H Nojima; M Oren
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.